Methotrexate Hydrate remains a cornerstone therapy in rheumatology and oncology due to its cost-effectiveness and well-established safety profile. As healthcare systems prioritize value-based care, this folate analog maintains relevance through new formulations and combination therapy protocols. However, manufacturers face increasing pressure from generics and must differentiate through improved delivery systems and expanded indications. Download FREE Sample Report: https://www.24chemicalresearch.com/download-sample/127052/north-america-methotrexate-hydrate-market